Associate Professor, Radiation Oncology, University of Florida College of Medicine
Radiation Oncology
Dr. Bradford S. Hoppe, MD
|
|
Give Review
Bradford Hoppe practices Radiation Oncology. He went to Weill Cornell Medical College of Cornell University. Weill Cornell Medical College of Cornell University is ranked 18 in research and 49 in primary care medicine He over the years received 2 awards: "James E. Lockwood, Jr. Professor in Proton Therapy" and "CMS Meaningful Use Stage 1 Certification". Doctor Bradford S. Hoppe, MD has written publications. He has 56 publications published with PubMed. The lastest publication is: 'Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.' Bradford Hoppe accepts Medicare.
Publications
- Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound.
- Re: Radiation for Prostate Cancer: Intensity Modulated Radiation Therapy versus Proton Beam: B. S. Hoppe, C. Bryant and H. M. Sandler J Urol 2015;193:1089-1091.
- Radiation for Prostate Cancer: Intensity Modulated Radiation Therapy versus Proton Beam.
- Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin Lymphoma.
- Rectal Toxicity After Proton Therapy For Prostate Cancer: An Analysis of Outcomes of Prospective Studies Conducted at the University of Florida Proton Therapy Institute.
- ACR Appropriateness Criteria Follow-up of Hodgkin Lymphoma.
- Involved-Node Proton Therapy in Combined Modality Therapy for Hodgkin Lymphoma: Results of a Phase 2 Study.
- Proton therapy for Hodgkin Lymphoma.
- Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
- Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate Cancer.
- Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal Cancer.
- RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemci...
- Hemorrhagic Radiation Cystitis.
- Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate Cancer.
- ACR Appropriateness Criteria: Localized nodal indolent Lymphoma.
- Postoperative Proton Therapy in the Management of Stage III Thymoma.
- Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate Cancer is not associated with post-treatment testosterone suppression.
- Proton therapy with concomitant capecitabine for pancreatic and ampullary Cancers is associated with a low incidence of gastrointestinal toxicity.
- Proton therapy in a pediatric patient with stage III Hodgkin Lymphoma.
- Outcomes in men with large prostates (? 60 cm(3)) treated with definitive proton therapy for prostate Cancer.
- Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung Cancer.
- Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate Cancer: Results of two prospective trials.
- Management of Radiation Proctitis.
- Hip fractures and pain following proton therapy for management of prostate Cancer.
- Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy.
- Improving the therapeutic ratio in Hodgkin Lymphoma through the use of proton therapy.
- Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate Cancer in men 60 years old and younger.
- Protons Offer Reduced Normal-Tissue Exposure for Patients Receiving Postoperative Radiotherapy for Resected Pancreatic Head Cancer.
- When is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer?
- Improving the Therapeutic Ratio by Using Proton Therapy in Patients With Stage I or II Seminoma.
- Consolidative Involved-Node Proton Therapy for Stage IA-IIIB Mediastinal Hodgkin Lymphoma: Preliminary Dosimetric Outcomes from a Phase II Study.
- Proton radiation therapy offers reduced normal Lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-sma...
- Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer.
- Outcomes of Patients with Non-Hodgkin's Lymphoma Treated with Bexxar With or Without External-Beam Radiotherapy.
- Proton Radiotherapy for Prostate Cancer Is Not Associated With Post-Treatment Testosterone Suppression.
- Early outcomes from three prospective trials of image-guided proton therapy for prostate Cancer.
- Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung Cancer: who's at risk?
- Unresectable carcinoma of the paranasal sinuses: outcomes and toxicities.
- Postoperative intensity-modulated radiation therapy for Cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
- Involved-field radiotherapy before high-dose therapy and autologous stem-cell rescue in diffuse large-cell Lymphoma: long-term disease control and toxicity.
- Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience.
- Treatment of nasal cavity and paranasal sinus Cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience.
- Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin Lymphoma.
- Double-scattered proton-based stereotactic body radiotherapy for stage I lung Cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy.
- Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases.
- The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell Lymphoma.
- Patterns and incidence of neural invasion in patients with Cancers of the paranasal sinuses.
- Proton therapy for prostate Cancer.
- Costs of treatment and outcomes associated with second-line therapy and greater for relapsed ovarian Cancer.
- Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma.
- Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung Cancer.
- The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian Cancer in heavily pretreated patients.
- Experiences with a compound method for estimating the time since death. I. Rectal temperature nomogram for time since death.
- Complementation of the radiosensitive M059J cell line.
- Proton therapy in the management of Lymphoma.
Schools
Kaiser Permanente Oakland Medical Center
Memorial Sloan Kettering Cencer Center
Stanford University
Procedures Preformed
- Radiation Oncology Procedures
- Radiation Therapy
Conditions Treated
- Breast Cancer
- Lung Cancer
- Lymphoma
- Prostate Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- James E. Lockwood, Jr. Professor in Proton Therapy
- CMS Meaningful Use Stage 1 Certification
Education
-
Memorial Sloan-Kettering Cancer Center -
Kaiser Permanente Medical Group -
Weill Cornell Medical College of Cornell University
Hospital
-
UF Health Shands Hospital -
UF Health Jacksonville
Drug Facts
| NPI NUMBER | 1275791055 | |
| NPPES Provider LastName | HOPPE | |
| NPPES Provider FirstName | BRADFORD | |
| NPPES Provider ZIPCode | 322063531 | |
| NPPES Provider State | FL | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 199.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275791055 |
| Last Name Of The Provider | HOPPE |
| First Name Of The Provider | BRADFORD |
| View All |
Similar Doctors
|
Dr. Niraj H. Pahlajani, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Carlos E. Vargas Moncaleano, MD |
|
Dr. Alan R. Forbes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark E. Augspurger, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Randal H. Henderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer L. Peterson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Buskirk, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ryan S. Perkins, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Cynthia S. Anderson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary Koshy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sonja L. Schoeppel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ramesh Vedula, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John W. Wells, MD |
|
|
Dr. Laura A. Vallow, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Shyam B. Paryani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Julie A. Bradley, MD
This Doctor is OpenDoctor Recommended.
|